Biorem Inc. (BRM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 6,817 | 16,941 | 11,253 | 9,431 | 4,730 |
| Cost of Goods | 5,425 | 11,000 | 8,087 | 6,881 | 3,621 |
| Gross Profit | 1,392 | 5,941 | 3,166 | 2,550 | 1,110 |
| Operating Expenses | 1,207 | 2,093 | 1,570 | 1,492 | 1,037 |
| Operating Income | 185 | 3,848 | 1,595 | 1,058 | 73 |
| Interest Expense | 36 | 39 | 38 | 41 | 44 |
| Other Income | 123 | -119 | 18 | -4 | 21 |
| Pre-tax Income | 272 | 3,690 | 1,575 | 1,013 | 51 |
| Income Tax | 71 | 813 | 417 | 269 | 13 |
| Net Income Continuous | 201 | 2,877 | 1,158 | 745 | 37 |
| Net Income | $201 | $2,877 | $1,158 | $745 | $37 |
| EPS Basic Total Ops | 0.01 | 0.17 | 0.07 | 0.05 | 0.00 |
| EPS Basic Continuous Ops | 0.01 | 0.17 | 0.07 | 0.05 | 0.00 |
| EPS Diluted Total Ops | 0.01 | 0.16 | 0.06 | 0.04 | 0.00 |
| EPS Diluted Continuous Ops | 0.01 | 0.16 | 0.06 | 0.04 | 0.00 |
| EBITDA(a) | $399 | $3,824 | $1,746 | $1,163 | $229 |